News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Juno Therapeutics has agreed to settle litigation with Novartis and the Trustees of the University of Pennsylvania after Juno entered into a December 2013 license agreement with St. Jude Children’s Research Hospital, which owned the patent rights.
Bristol-Myers Squibb will use uniQure’s insect-cell based technology and manufacturing facilities to develop gene therapies for cardiovascular diseases in a deal potentially worth $2bn (€1.8bn).
Eurofins Bioanalytical Services has announced it will offer an extra-sensitive immunoassay service for biopharma developers.